DRD4 genotyping may differentiate symptoms of attention-deficit/hyperactivity disorder and sluggish cognitive tempo
Hilmi Bolat(Balıkesir University), Haluk Akın(Fırat University), Gül Ünsel‐Bolat(Balıkesir University), Kemal Utku Yazıcı(Ege University), Akın Tahıllıoğlu(Ege University), Ali Bacanlı(Başkent University), Buket Kosova(Ege University), Duygu Aygüneş Jafari(Ege University), Erhan Parıltay(Ege University), Semiha Özgül(Ege University), Eyüp Sabri Ercan(Ege University), Luís Augusto Rohde(Hospital de Clínicas de Porto Alegre)
Cited by 33
Related Papers
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
|American Journal of Psychiatry|2007|5.3k
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders
|Cell|2019|1.5k
The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder
|Neuroscience & Biobehavioral Reviews|2021|1.4k
Attention-deficit/hyperactivity disorder
|Nature Reviews Disease Primers|2015|1.3k
Joint Analysis of the DRD5 Marker Concludes Association with Attention-Deficit/Hyperactivity Disorder Confined to the Predominantly Inattentive and Combined Subtypes
|The American Journal of Human Genetics|2004|184